Mednet Logo
HomeGynecologic OncologyQuestion

Will you be changing your management of locally advanced cervical cancer based on the results of the recently published INTERLACE trial?

4
3 Answers
Mednet Member
Mednet Member
Radiation Oncology · NYU Langone Medical Center

Absolutely NOT. INTERLACE results are in abstract form only, including early-stage disease I-II at 86%, and the details regarding radiation are minimal, stating it's prescribed to point A and recommend CT/MR planning (we do not know how many patients underwent image-guided brachytherapy).

Also, ind...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

I think it is too early to commit all patients to induction chemo, based on what I know about this study. It is important to review the details of the study, as mentioned by Dr. @Dr. First Last. In addition, it is important to understand the differences between studies that led to an overall surviva...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would wait for the publications for details including brachytherapy and recurrence pattern but could potentially be practice-changing.

Register or Sign In to see full answer

Will you be changing your management of locally advanced cervical cancer based on the results of the recently published INTERLACE trial? | Mednet